MARKER THERAPEUTICS INC
MRKR · NASDAQ
Updated at 2026-10-15 08:35:28
- Today's High
- $0.95
- Today’s Low
- $0.88
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $0.92
- Previous Close
- $0.89
- Volume
- 65.81K
- Market Cap
- $14.84M
- P/E Ratio
- --
- EPS
- $-0.89
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 2450 HOLCOMBE BLVD, HOUSTON, TX, UNITED STATES, 77021
- Country
- US
- Listing Date
- 2016-11-08
- Fiscal Year End
- December
- Shares Outstanding
- 16.67M
- CIK
- 0001094038
- Website
- markertherapeutics.com
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, is dedicated to the development and commercialization of various T-cell-based immunotherapies and peptide-based vaccines for the treatment of hematologic malignancies and solid tumor indications. The company is headquartered in Houston, Texas.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$1.1M
2025-09-30
$1.23M
Operating Expenses
2026-06-30
$2.62M
2026-03-31
$1.22M
2025-12-31
$1.88M
2025-09-30
$1.02M
Net Income
2026-06-30
-$1.82M
2026-03-31
-$3.17M
2025-12-31
-$1.7M
2025-09-30
-$1.99M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
-154.35%
2025-09-30
-162.1%
Earnings Per Share
2026-06-30
$-0.09
2026-03-31
$-0.16
2025-12-31
$-0.04
2025-09-30
$-0.12
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$1.82M
2026-03-31
-$3.17M
2025-12-31
-$1.71M
2025-09-30
-$1.99M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
0.88%
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $1.1M | $1.23M |
| Operating Expenses | $2.62M | $1.22M | $1.88M | $1.02M |
| Net Income | -$1.82M | -$3.17M | -$1.7M | -$1.99M |
| Net Profit Margin | -- | -- | -154.35% | -162.1% |
| Earnings Per Share | $-0.09 | $-0.16 | $-0.04 | $-0.12 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$1.82M | -$3.17M | -$1.71M | -$1.99M |
| Effective Tax Rate | -- | -- | 0.88% | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.